Clinical Scorecard: Persistent Changes in Gut Microbiome Profile in Cushing's Syndrome After Remission

At a Glance

Key Highlights

• Patients with active Cushing's syndrome exhibit a distinct and disturbed gut microbiome compared to healthy lean controls.
• Microbial dysbiosis persists even 1 to 2 years after biochemical remission following curative surgery.
• Persistent gut microbiome alterations may contribute to ongoing morbidity despite biochemical cure and represent a potential target for probiotic interventions.

Guideline-Based Recommendations

Diagnosis

• Confirm Cushing's syndrome using urinary free cortisol, late-night salivary cortisol, and 1-mg overnight dexamethasone suppression test.
• Perform further subtyping according to Endocrine Society guidelines.

Management

• First-line treatment is surgical removal of the cortisol-producing tumor or lesion.
• Postoperative glucocorticoid replacement therapy with hydrocortisone is required and tapered based on hypothalamic-pituitary-adrenal axis recovery.

Monitoring & Follow-up

• Long-term biochemical monitoring to confirm remission of hypercortisolism.
• Assessment of infectious complications and metabolic/cardiovascular comorbidities during follow-up.

Risks

• Persistent metabolic and cardiovascular morbidity despite biochemical remission.
• Potential long-lasting imprinting effects of hypercortisolism on biological systems including gut microbiome.

Patient & Prescribing Data

Patients with endogenous Cushing's syndrome undergoing surgical treatment and remission

Standard glucocorticoid replacement therapy post-surgery with hydrocortisone, tapered over time; no current microbiome-targeted therapies but probiotics may be considered in future.

Clinical Best Practices

• Use multiple biochemical tests to accurately diagnose and subtype Cushing's syndrome.
• Ensure long-term follow-up after surgical cure to monitor for persistent comorbidities and microbiome alterations.
• Consider the gut microbiome as a potential therapeutic target to improve patient outcomes post-remission.
• Exclude recent antibiotic use before microbiome analysis to avoid confounding effects.

References

• Endocrine Society Clinical Practice Guideline for Cushing's Syndrome
• Zhang et al. Study on Gut Microbiome in Cushing's Syndrome
• Valassi et al. Microbial Richness in Cushing's Disease Remission